Franklin Resources’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.7M | Buy |
934,222
+151,248
| +19% | +$5.45M | 0.01% | 753 |
|
|
2025
Q1 | $24.4M | Buy |
782,974
+243,493
| +45% | +$7.58M | 0.01% | 835 |
|
|
2024
Q4 | $13.8M | Sell |
539,481
-921,034
| -63% | -$23.5M | ﹤0.01% | 1016 |
|
|
2024
Q3 | $40.7M | Buy |
1,460,515
+70,130
| +5% | +$1.95M | 0.01% | 673 |
|
|
2024
Q2 | $36.7M | Buy |
1,390,385
+165,012
| +13% | +$4.35M | 0.01% | 650 |
|
|
2024
Q1 | $37.2M | Buy |
1,225,373
+1,129,012
| +1,172% | +$34.3M | 0.01% | 667 |
|
|
2023
Q4 | $2.71M | Buy |
96,361
+25,716
| +36% | +$722K | ﹤0.01% | 1298 |
|
|
2023
Q3 | $1.92M | Buy |
70,645
+16,657
| +31% | +$452K | ﹤0.01% | 1400 |
|
|
2023
Q2 | $1.66M | Buy |
53,988
+13,268
| +33% | +$408K | ﹤0.01% | 1471 |
|
|
2023
Q1 | $1.47M | Sell |
40,720
-1,085
| -3% | -$39.1K | ﹤0.01% | 1424 |
|
|
2022
Q4 | $1.65M | Buy |
41,805
+15,702
| +60% | +$621K | ﹤0.01% | 1416 |
|
|
2022
Q3 | $1.05M | Sell |
26,103
-107,946
| -81% | -$4.34M | ﹤0.01% | 1503 |
|
|
2022
Q2 | $5.64M | Buy |
134,049
+3,478
| +3% | +$146K | ﹤0.01% | 1081 |
|
|
2022
Q1 | $5.09M | Buy |
130,571
+791
| +0.6% | +$30.8K | ﹤0.01% | 1164 |
|
|
2021
Q4 | $5.17M | Buy |
129,780
+117,170
| +929% | +$4.67M | ﹤0.01% | 1212 |
|
|
2021
Q3 | $456K | Sell |
12,610
-401,943
| -97% | -$14.5M | ﹤0.01% | 1922 |
|
|
2021
Q2 | $17M | Sell |
414,553
-705,952
| -63% | -$28.9M | 0.01% | 899 |
|
|
2021
Q1 | $48.9M | Buy |
1,120,505
+2,301
| +0.2% | +$100K | 0.02% | 626 |
|
|
2020
Q4 | $56M | Sell |
1,118,204
-73,218
| -6% | -$3.66M | 0.02% | 557 |
|
|
2020
Q3 | $50.1M | Sell |
1,191,422
-8,578
| -0.7% | -$361K | 0.02% | 552 |
|
|
2020
Q2 | $51.7M | Buy |
+1,200,000
| New | +$51.7M | 0.03% | 518 |
|